Targeting the oxidative stress-neuroinflammation axis: the mechanism of arctigenin’s broad-spectrum analgesia with limited side effects
The present study is the first to provide evidences that AG may represent a novel therapeutic target with high analgesic activity and low side effects for the treatment of neuropathic pain.
Authors
- Yan Xu (ORCID: https://orcid.org/0000-0003-0379-8866)
- W B Li
- Ping Lu (ORCID: https://orcid.org/0009-0000-7236-8355)
- Jinglei Liao
- J R Jiang
- Chen Lu
- Zhe Wang
- Shu Li
Institutions
- Shihezi University (CN)
- Xuzhou University of Technology (CN)
- Xuzhou Medical College (CN)
- Xuzhou Children Hospital (CN)
- Maternal and Child Health Hospital of Xuzhou (CN)
Publication Details
- Journal
- Frontiers in Immunology
- Published
- 2026-03-05
- DOI
- https://doi.org/10.3389/fimmu.2026.1754756
- Primary Topic
- Plant-derived Lignans Synthesis and Bioactivity
- Type
- article
- Field-Weighted Citation Impact
- 0.00